findmyKOL
Clinical trialNCT07300150RecruitingPhase 1Interventional

A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors

SponsorPAQ Therapeutics, Inc.Enrollment210Colorectal CancerNon-Small Cell Lung CancerPancreatic CancerSolid Tumor
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

South Korea
  • Samsung Medical Center

    Seoul, South Korea

    Recruiting
  • Seoul National University Bundang Hospital

    Seoul, South Korea

    Recruiting
  • Seoul National University Hospital

    Seoul, South Korea

    Recruiting
  • Severance Hospital, Yonsei University Health System

    Seoul, South Korea

    Recruiting
United States
  • Dana-Farber/massachusetts General Hospital, Inc

    Boston, Massachusetts, United States

    Recruiting
  • New Experimental Therapeutics of San Antonio Llc

    San Antonio, Texas, United States

    Recruiting
  • Start - South Texas Accelerated Research Therapeutics, Llc

    San Antonio, Texas, United States

    Recruiting
  • Start Mountain Region

    West Valley City, Utah, United States

    Recruiting
  • Next Virginia

    Fairfax, Virginia, United States

    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
21 Nov 2025
Primary completion
18 Oct 2028
Completion
18 Oct 2028
Last update posted
6 Jul 2026
Registered enrollment
210
Registry id
NCT07300150

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.